These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35579125)

  • 1. Hyper-Eosinophilic Syndrome with Myocarditis after Inactivated SARSCoV- 2 Vaccination - A Case Study.
    Tiwari A; Karna G; Chakrabarti SS; Panda PK; Kaur U
    Curr Drug Saf; 2023; 18(1):103-106. PubMed ID: 35579125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
    Lee ASY; Balakrishnan IDD; Khoo CY; Ng CT; Loh JKX; Chan LL; Teo LLY; Sim DKL
    Heart Lung Circ; 2022 Jun; 31(6):757-765. PubMed ID: 35227610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Facing COVID-19 : myocarditis following vaccination with mRNA SARS-CoV-2].
    Weerts V; Lempereur M; Léonard P; Lancellotti P
    Rev Med Liege; 2023 Mar; 78(3):141-146. PubMed ID: 36924151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review.
    Doman T; Saito H; Tanaka Y; Hirasawa D; Endo M; Togo D; Matsuda T
    Intern Med; 2023 Mar; 62(6):865-869. PubMed ID: 36575012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
    Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS
    AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocarditis Following COVID-19 Vaccination: A Systematic Review of Case Reports.
    Behers BJ; Patrick GA; Jones JM; Carr RA; Behers BM; Melchor J; Rahl DE; Guerriero TD; Zhang H; Ozkardes C; Thomas ND; Sweeney MJ
    Yale J Biol Med; 2022 Jun; 95(2):237-247. PubMed ID: 35782472
    [No Abstract]   [Full Text] [Related]  

  • 9. A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.
    Schroeder JW; Gamba C; Toniato A; ; Rongioletti F
    Clin Dermatol; 2022; 40(5):591-594. PubMed ID: 35550918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated vaccine Covaxin/BBV152: A systematic review.
    Ahmed TI; Rishi S; Irshad S; Aggarwal J; Happa K; Mansoor S
    Front Immunol; 2022; 13():863162. PubMed ID: 36016940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID vaccine-associated myocarditis in an 8-year-old patient.
    Mehta K; Cohen R; Kelly B; Grosse-Wortmann L
    Cardiol Young; 2023 Feb; 33(2):334-335. PubMed ID: 35892184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).
    Sunagar R; Prasad SD; Ella R; Vadrevu KM
    Front Immunol; 2022; 13():1063679. PubMed ID: 36569867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
    Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
    Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study.
    Vadrevu KM; Reddy S; Jogdand H; Ganneru B; Mirza N; Tripathy VN; Singh C; Khalatkar V; Prasanth S; Rai S; Ella R; Blackwelder W; Prasad S; Ella K
    Lancet Infect Dis; 2022 Sep; 22(9):1303-1312. PubMed ID: 35717995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
    Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
    JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.
    Ella R; Reddy S; Jogdand H; Sarangi V; Ganneru B; Prasad S; Das D; Raju D; Praturi U; Sapkal G; Yadav P; Reddy P; Verma S; Singh C; Redkar SV; Gillurkar CS; Kushwaha JS; Mohapatra S; Bhate A; Rai S; Panda S; Abraham P; Gupta N; Ella K; Bhargava B; Vadrevu KM
    Lancet Infect Dis; 2021 Jul; 21(7):950-961. PubMed ID: 33705727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis With COVID-19 mRNA Vaccines.
    Bozkurt B; Kamat I; Hotez PJ
    Circulation; 2021 Aug; 144(6):471-484. PubMed ID: 34281357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.